Overview
- BETA Technologies completed the eIPP’s first operational missions on Friday, July 10, flying its ALIA CX300 conventional takeoff‑and‑landing aircraft to carry manufactured organs between airports in Maryland and Virginia.
- The flights covered roughly 250–275 nautical miles and were run with United Therapeutics and the Multistate Collaborative to test time‑sensitive medical logistics over a multi‑state corridor.
- The eIPP covers eight selected projects across a 26‑state footprint and BETA was chosen to participate in seven projects, which will generate real‑world operations data over at least three years for the FAA and DOT.
- BETA says the CX300 is on a path for conventional aircraft certification as early as 2027 and expects eVTOL certification around 2028, though those timelines are company projections and will depend on FAA review of the program data.
- Regulators and industry see these trials as a testbed for infrastructure, charging networks and operational procedures that could lower costs for medical cargo but the wider eVTOL sector still faces regulatory complexity and investor skepticism that could slow commercial rollouts.